Microvascular dysfunction of the non-culprit circulation predicts poor prognosis in patients with ST-segment elevation myocardial infarction

被引:3
|
作者
Flores, Cristian Herrera [1 ,2 ]
Diez-Delhoyo, Felipe [1 ,2 ]
Sanz-Ruiz, Ricardo [1 ,2 ]
Vazquez-Alvarez, Maria Eugenia [1 ,2 ]
Delpon, Maria Tamargo [1 ,2 ]
Triguero, Javier Soriano [1 ,2 ]
Corrales, Jaime Elizaga [1 ,2 ]
Fernandez-Aviles, Francisco [1 ,2 ]
Ibanes, Enrique Gutierrez [1 ,2 ,3 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Dept Cardiol, Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain
[2] Univ Complutense Madrid, Fac Med, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Serv Cardiol, C-Dr Esquerdo 46, Madrid 28007, Spain
来源
IJC HEART & VASCULATURE | 2022年 / 39卷
关键词
Acetylcholine; Endothelium; Cardiovascular outcomes; Microcirculation; Myocardial infarction; FRACTIONAL FLOW RESERVE; CORONARY BLOOD-FLOW; MICROCIRCULATORY RESISTANCE; ENDOTHELIAL DYSFUNCTION; MULTIVESSEL DISEASE; CLINICAL-OUTCOMES; ANGIOPLASTY; REVASCULARIZATION; INTERVENTION; IMPACT;
D O I
10.1016/j.ijcha.2022.100997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endothelial and microvascular dysfunction are frequently found in the non-culprit territory in patients with acute myocardial infarction (AMI). We aimed to determine whether an impaired coronary physiology of the non-culprit territory impacts long-term prognosis. Methods: FISIOIAM was an observational single-center study which included patients with AMI and another coronary artery lesion in a different territory. Intracoronary physiology of the non-culprit artery was analyzed early after primary percutaneous coronary intervention of the culprit artery, using fractional flow reserve (FFR), index of microcirculatory resistance (IMR), coronary flow reserve (CFR), endothelium-dependent CFR (eCFR) and macrovascular endothelial function . Patients were followed for a composite outcome of cardiovascular death, non-fatal myocardial infarction, coronary revascularization, and hospitalization due to heart failure or unstable angina. Results: A total of 84 patients (mean age: 62 +/- 10 years) were included and functional abnormalities were detected in 93% of them. During follow-up (median of 1422 days; interquartile range, 1287-1634), 13.1% of the patients experienced at least one adverse cardiovascular event. Kaplan-Meier analysis revealed that patients with a CFR < 2 had a higher risk of events (Hazard Ratio, HR: 4.97, 95% Confidence Interval, CI, 1.32-18.75), whereas other parameters such as FFR, IMR, eCFR, and macrovascular endothelial function had no effect. A low CFR was an independent predictor of cardiovascular events, even after adjustment for age and traditional cardiovascular risk factors (adjusted HR: 6.62, 95% CI, 1.30-33.70). Conclusions: The presence of abnormal coronary microvascular function as measured by a CFR < 2 in the non culprit territory predicts future risk of adverse cardiovascular events.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Optical coherence tomography findings in non-culprit lesions in patients with ST-segment elevation myocardial infarction
    Garcia-Guimaraes, M.
    Bastante, T.
    Maruri, R.
    Cuesta, J.
    Rivero, F.
    Alfonso, F.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 474 - 474
  • [2] Interrogation of Non-culprit Stenoses in Patients With St-segment Elevation Myocardial Infarction: A Comparison Between Ffr and Ifr
    van der Hoeven, Nina W.
    Janssens, Gladys N.
    de Waard, Guus A.
    Everaars, Henk
    Beijnink, Casper W. H.
    van de Ven, Peter M.
    Nijveldt, Robin
    Diletti, Roberto
    Cook, Christopher M.
    Davies, Justin E.
    van Leeuwen, Maarten A. H.
    van Royen, Niels
    [J]. CIRCULATION, 2017, 136
  • [3] Invasive and non-invasive assessment of non-culprit coronary lesions in patients with ST-segment elevation myocardial infarction
    Ferruzzi, Germano Junior
    Bellino, Michele
    Silverio, Angelo
    Di Maio, Marco
    Vassallo, Mariagiovanna
    Vecchione, Carmine
    Galasso, Gennaro
    [J]. TRANSLATIONAL MEDICINE AT UNISA, 2024, 26 (01):
  • [4] Ruptured "non-culprit" in-stent neoatherosclerosis during ST-segment elevation acute myocardial infarction
    Cuesta, Javier
    Rivero, Fernando
    Bastante, Teresa
    Benedicto, Amparo
    Alfonso, Fernando
    [J]. EUROINTERVENTION, 2016, 12 (10) : 1222 - 1222
  • [5] HYPERTENSION, MICROVASCULAR PATHOLOGY AND PROGNOSIS IN PATIENTS WITH AN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Berry, Colin
    Carrick, David
    Ahmed, Nadeem
    Carberry, Jaclyn
    May, Vannesa T. Y.
    McEntegart, Margaret
    Eteiba, Hany
    Lindsay, Martin
    Hood, Stuart
    Watkins, Stuart
    Davie, Andrew
    Mahrous, Ahmed
    Mordi, Ify
    Ford, Ian
    Radjenovic, Aleksandra
    Oldroyd, Keith
    Haig, Caroline
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1617 - 1617
  • [6] Fractional flow reserve for non-culprit disease in ST-segment elevation myocardial infarction: first do no harm?
    Henderson, Robert A.
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (03) : 181 - 183
  • [7] Clinical and Angiographic Predictors of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
    Baek, Yong-Soo
    Park, Sang-Don
    Kim, Soo-Han
    Lee, Man-Jong
    Shin, Sung-Hee
    Kim, Dae-Hyeok
    Kwan, Jun
    Park, Keum-Soo
    Woo, Seong-Ill
    [J]. YONSEI MEDICAL JOURNAL, 2015, 56 (05) : 1235 - 1243
  • [8] Culprit lesion severity in ST-segment elevation myocardial infarction
    Razzini, Cinzia
    Sarkar, Kunal
    Romeo, Fransesco
    Sachdeva, Rajesh
    Mehta, Jawahar L.
    [J]. CHEST, 2007, 132 (04) : 544S - 544S
  • [9] aVR ST-segment changes and prognosis of ST-segment elevation myocardial infarction
    Sedighi, Sogol
    Fattahi, Mustafa
    Dehghani, Pooyan
    Aslani, Amir
    Namdar, Zahra Mehdipour
    Hassanzadeh, Mani
    [J]. HEALTH SCIENCE REPORTS, 2021, 4 (04)
  • [10] Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction
    Zhao, Bo
    Peng, Jianjun
    Ren, Lihui
    Lei, Licheng
    Wang, Zuoyan
    Ye, Huiming
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 4147 - 4153